Literature DB >> 34432240

Mechanistic and Structural Features of PROTAC Ternary Complexes.

Ryan Casement1, Adam Bond1, Conner Craigon1, Alessio Ciulli2.   

Abstract

The rapid and ever-growing advancements from within the field of proteolysis-targeting chimeras (PROTAC)-induced protein degradation have driven considerable development to gain a deeper understanding of their mode of action. The ternary complex formed by PROTACs with their target protein and E3 ubiquitin ligase is the key species in their substoichiometric catalytic mechanism. Here, we describe the theoretical framework that underpins ternary complexes, including a current understanding of the three-component binding model, cooperativity, hook effect and structural considerations. We discuss in detail the biophysical methods used to interrogate ternary complex formation in vitro, including X-ray crystallography, AlphaLISA, FRET, FP, ITC and SPR. Finally, we provide detailed ITC methods and discuss approaches to assess binary and ternary target engagement, target ubiquitination and degradation that can be used to obtain a more holistic understanding of the mode of action within a cellular environment.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biophysical methods, crystal structures; Cooperativity; E3 ubiquitin ligase; Hook effect; Protein ubiquitination; Target engagement; Targeted protein degradation (TPD); Ternary complex; proteolysis-targeting chimeras (PROTACs)

Mesh:

Substances:

Year:  2021        PMID: 34432240     DOI: 10.1007/978-1-0716-1665-9_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  55 in total

1.  Exact analysis of ligand-induced dimerization of monomeric receptors.

Authors:  Eric T Mack; Raquel Perez-Castillejos; Zhigang Suo; George M Whitesides
Journal:  Anal Chem       Date:  2008-06-11       Impact factor: 6.986

2.  Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody, Abegrin.

Authors:  Kathy Mulgrew; Krista Kinneer; Xiao-Tao Yao; Beth K Ward; Melissa M Damschroder; Bill Walsh; Su-Yau Mao; Changshou Gao; Peter A Kiener; Steve Coats; Michael S Kinch; David A Tice
Journal:  Mol Cancer Ther       Date:  2006-12       Impact factor: 6.261

3.  Structural basis of lenalidomide-induced CK1α degradation by the CRL4(CRBN) ubiquitin ligase.

Authors:  Georg Petzold; Eric S Fischer; Nicolas H Thomä
Journal:  Nature       Date:  2016-02-24       Impact factor: 49.962

4.  Bacteriolytic Power of Immune Serum and the Theory of Complement Diversion.

Authors:  B H Buxton
Journal:  J Med Res       Date:  1905-08

Review 5.  Bispecific antibodies: a mechanistic review of the pipeline.

Authors:  Aran F Labrijn; Maarten L Janmaat; Janice M Reichert; Paul W H I Parren
Journal:  Nat Rev Drug Discov       Date:  2019-08       Impact factor: 84.694

Review 6.  Inducing protein-protein interactions with molecular glues.

Authors:  Ye Che; Adam M Gilbert; Veerabahu Shanmugasundaram; Mark C Noe
Journal:  Bioorg Med Chem Lett       Date:  2018-04-19       Impact factor: 2.823

7.  A comprehensive mathematical model for three-body binding equilibria.

Authors:  Eugene F Douglass; Chad J Miller; Gerson Sparer; Harold Shapiro; David A Spiegel
Journal:  J Am Chem Soc       Date:  2013-04-16       Impact factor: 15.419

8.  Potent and selective bivalent inhibitors of BET bromodomains.

Authors:  Michael J Waring; Huawei Chen; Alfred A Rabow; Graeme Walker; Romel Bobby; Scott Boiko; Rob H Bradbury; Rowena Callis; Edwin Clark; Ian Dale; Danette L Daniels; Austin Dulak; Liz Flavell; Geoff Holdgate; Thomas A Jowitt; Alexey Kikhney; Mark McAlister; Jacqui Méndez; Derek Ogg; Joe Patel; Philip Petteruti; Graeme R Robb; Matthew B Robers; Sakina Saif; Natalie Stratton; Dmitri I Svergun; Wenxian Wang; David Whittaker; David M Wilson; Yi Yao
Journal:  Nat Chem Biol       Date:  2016-10-24       Impact factor: 15.040

9.  Design and characterization of bivalent BET inhibitors.

Authors:  Minoru Tanaka; Justin M Roberts; Hyuk-Soo Seo; Amanda Souza; Joshiawa Paulk; Thomas G Scott; Stephen L DeAngelo; Sirano Dhe-Paganon; James E Bradner
Journal:  Nat Chem Biol       Date:  2016-10-24       Impact factor: 15.040

Review 10.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24
View more
  4 in total

1.  Deubiquitinase-targeting chimeras for targeted protein stabilization.

Authors:  Nathaniel J Henning; Lydia Boike; Jessica N Spradlin; Carl C Ward; Gang Liu; Erika Zhang; Bridget P Belcher; Scott M Brittain; Matthew J Hesse; Dustin Dovala; Lynn M McGregor; Rachel Valdez Misiolek; Lindsey W Plasschaert; David J Rowlands; Feng Wang; Andreas O Frank; Daniel Fuller; Abigail R Estes; Katelyn L Randal; Anoohya Panidapu; Jeffrey M McKenna; John A Tallarico; Markus Schirle; Daniel K Nomura
Journal:  Nat Chem Biol       Date:  2022-02-24       Impact factor: 16.174

Review 2.  Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs.

Authors:  Ruth Nussinov; Mingzhen Zhang; Ryan Maloney; Yonglan Liu; Chung-Jung Tsai; Hyunbum Jang
Journal:  J Mol Biol       Date:  2022-04-01       Impact factor: 6.151

3.  A Temporal PROTAC Cocktail-Mediated Sequential Degradation of AURKA Abrogates Acute Myeloid Leukemia Stem Cells.

Authors:  Fang Liu; Xuan Wang; Jianli Duan; Zhijie Hou; Zhouming Wu; Lingling Liu; Hanqi Lei; Dan Huang; Yifei Ren; Yue Wang; Xinyan Li; Junxiao Zhuo; Zijian Zhang; Bin He; Min Yan; Huiming Yuan; Lihua Zhang; Jinsong Yan; Shijun Wen; Zifeng Wang; Quentin Liu
Journal:  Adv Sci (Weinh)       Date:  2022-06-02       Impact factor: 17.521

4.  Predicting the structural basis of targeted protein degradation by integrating molecular dynamics simulations with structural mass spectrometry.

Authors:  Tom Dixon; Derek MacPherson; Barmak Mostofian; Taras Dauzhenka; Samuel Lotz; Dwight McGee; Sharon Shechter; Utsab R Shrestha; Rafal Wiewiora; Zachary A McDargh; Fen Pei; Rajat Pal; João V Ribeiro; Tanner Wilkerson; Vipin Sachdeva; Ning Gao; Shourya Jain; Samuel Sparks; Yunxing Li; Alexander Vinitsky; Xin Zhang; Asghar M Razavi; István Kolossváry; Jason Imbriglio; Artem Evdokimov; Louise Bergeron; Wenchang Zhou; Jagat Adhikari; Benjamin Ruprecht; Alex Dickson; Huafeng Xu; Woody Sherman; Jesus A Izaguirre
Journal:  Nat Commun       Date:  2022-10-06       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.